作者: O N Egorova , R M Balabanova , O N Egorova , R M Balabanova
DOI: 10.14412/1996-7012-2008-513
关键词: Clinical trial 、 Osteoporosis 、 Medicine 、 Rheumatology 、 Internal medicine 、 Combined use 、 Meloxicam 、 Drug 、 Pain syndrome 、 Surgery 、 Cog
摘要: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in complex therapy for pain syndrome rheumatology. The paper describes the pathophysiological mechanisms responsible development of chronic and acute pain. It details action cyclooxygenase types 1 2 (COG COG 2), shows key role induction transmission. data clinical trials meloxicam that inhibits mainly given. drug is highly effective treating rheumatic diseases, particularly old-age group patients with osteoporosis. combined use different formulations makes it possible to choose adequate, maximally individualized treatment relieve shortest time. Among NSAIDs, an optimum efficacy-safety ratio.